Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cut-point for Ki-67 proliferation index as a prognostic marker for glioblastoma

Published:2018-01-16 Issue:1 Volume:15 Page:5-9
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Wong Eugene¹²^ORCID,Nahar Najmun³,Hau Eric¹³,Varikatt Winny¹⁴,Gebski Val³⁵,Ng Thomas⁴,Jayamohan Jayasingham³,Sundaresan Puma¹³^ORCID

Affiliation:

1. Sydney Medical School; University of Sydney; Sydney Australia

2. Royal North Shore Hospital; St Leonards NSW Australia

3. Department of Radiation Oncology; Crown Princess Mary Cancer Centre; Westmead Hospital; Westmead Australia

4. Department of Anatomical Pathology; ICPMR; Westmead NSW Australia

5. NHMRC Clinical Trials Centre; University of Sydney; Sydney Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12826/fullpdf

Reference18 articles.

1. Glioblastoma American Brain Tumour Association. American Brain Tumour Association

2. Epidemiologic and molecular prognostic review of glioblastoma;Thakkar;Cancer Epidemiol Biomarkers Prev,2014

3. Long-term survival with glioblastoma multiforme;Krex;Brain,2007

4. Communicating prognosis in cancer care: a systematic review of the literature;Hagerty;Ann Oncol,2005

5. Dangers of using “optimal” cutpoints in the evaluation of prognostic factors;Altman;J Natl Cancer Inst,1994

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. FAM83D: Negative regulator for glioma cell proliferation and inadequate indicator for the prognosis of gliomas;Gene Reports;2024-03

2. Association of MGMT Promoter and Enhancer Methylation with Genetic Variants, Clinical Parameters, and Demographic Characteristics in Glioblastoma;Cancers;2023-12-09

3. Temozolomide, Procarbazine and Nitrosoureas in the Therapy of Malignant Gliomas: Update of Mechanisms, Drug Resistance and Therapeutic Implications;Journal of Clinical Medicine;2023-11-30

4. General Clinico-Pathological Characteristics in Glioblastomas in Correlation with p53 and Ki67;Medicina;2023-10-30

5. Morphological and molecular-biological features of glioblastoma progression in tolerant and susceptible to hypoxia Wistar rats;Scientific Reports;2023-08-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3